Tradjenta
Utilized to manage type 2 diabetes mellitus to support glycaemic control.
- Category
- Diabetes Management
- Active ingredient
- Linagliptin
- Supply
- Pharmacy
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 5mg
Tradjenta details
- Condition
- Type 2 Diabetes Mellitus
- Alternative names
- Trajenta
- Therapeutic class
- Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
- Pharmacological class
- Gliptin
- Contraindications
- hypersensitivity to linagliptin; type 1 diabetes mellitus; diabetic ketoacidosis
- Minor side effects
- nasopharyngitis; upper respiratory tract infection; headache
- Moderate side effects
- hypoglycaemia
- Dosage forms
- Film-coated tablet
- Administration route
- Oral use
- Patient summary
- utilized to manage type 2 diabetes mellitus to support glycaemic control.
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- Boehringer Ingelheim
- Onset Time
- 1–2 weeks
- Duration
- 24 hours
- Storage instructions
- Store at room temperature away from moisture and direct light.
- Drug interactions
- rifampicin
- Age restrictions
- Not recommended for children and adolescents under 18 years.
Precautions and warnings
monitor for signs of pancreatitis; observe for skin reactions; avoid in patients with severe hepatic impairment
Serious side effects
acute pancreatitis, requires immediate medical attention; bullous pemphigoid, requires immediate medical attention; anaphylaxis, requires immediate medical attention
Mechanism of action
This medication functions as a selective inhibitor of the DPP-4 enzyme. By preventing the breakdown of incretin hormones, it stimulates insulin secretion and suppresses glucagon release in a glucose-dependent manner, thereby stabilizing blood sugar levels.
Pregnancy and breastfeeding
Pregnancy: Use is not recommended. Breastfeeding: Discuss benefits and risks with a physician.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Tradjenta
Tradjenta contains linagliptin, a medication indicated for the management of type 2 diabetes mellitus. The same active ingredient is sold elsewhere under the brand name Trajenta. Produced by Boehringer Ingelheim, this medication is supplied as a tablet in 5mg strength to assist with effective glucose regulation.
Buying Tradjenta online
Tradjenta is registered across 13 markets, including the UAE, Singapore and Hong Kong, with availability also in Thailand, Malaysia and the Philippines. Generic linagliptin remains a more affordable choice than the original brand, offering an accessible solution for expats and those living at a distance from local medical supplies. As a popular item across these regions, Tradjenta can be readily sourced for consistent, long-term health management.